YiChang HEC Pharmaceutical Merger Update
Company Announcements

YiChang HEC Pharmaceutical Merger Update

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558) has released an update.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is undergoing a proposed pre-conditional privatization by Sunshine Lake Pharma Co., Ltd. through a merger by absorption, which is still pending due to unfulfilled pre-conditions. The company has been working on preparing the necessary filings for listing the Offeror H Shares on the Stock Exchange, a process delayed by internal approval procedures and national holidays. Investors are cautioned that the merger is not assured and to exercise caution when dealing in the company’s securities.

For further insights into HK:1558 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App